Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

VIRACTA THERAPEUTICS, INC.

(VIRX)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Communiqués de presse de la société VIRACTA THERAPEUTICS, INC.
11/29Viracta Therapeutics Announces Orphan Drug Designation Granted by FDA for its All-Oral ..
PR
11/11Viracta Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporat..
AQ
11/10VIRACTA THERAPEUTICS, INC. Management's Discussion and Analysis of Financial Condition..
AQ
11/10Viracta Therapeutics Reports Third Quarter 2021 Financial Results and Provides Corporat..
PU
11/10SUNESIS : Q3 Earnings Snapshot
AQ
11/08Viracta Therapeutics Secures $50 Million Credit Facility from Silicon Valley Bank and O..
AQ
11/05Viracta Therapeutics Announces Upcoming Oral and Poster Presentations at the 2021 Ameri..
AQ
11/05Viracta Therapeutics Secures $50 Million Credit Facility from Silicon Valley Bank and O..
PU
11/05VIRACTA THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Termination of a ..
AQ
10/06VIRACTA THERAPEUTICS : Multinational trial expands Viracta's clinical-stage pipeline beyon..
PU
10/06VIRACTA THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
09/07VIRACTA : Therapeutics to Present at Upcoming Investor Conferences in September
PR
08/23VIRACTA THERAPEUTICS : Reacquires Exclusive Development and Commercialization Rights for i..
PU
08/23VIRACTA THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Termination of a ..
AQ
08/23VIRACTA : Therapeutics Reacquires Exclusive Development and Commercialization Rights for i..
PR
08/17VIRACTA THERAPEUTICS : Announces the Appointment of Flavia Borellini, Ph.D., and Jane F. B..
AQ
08/16VIRACTA THERAPEUTICS : Announces the Appointment of Flavia Borellini, Ph.D., and Jane F. B..
PU
08/16VIRACTA THERAPEUTICS, INC. : Change in Directors or Principal Officers, Regulation FD Disc..
AQ
08/12VIRACTA THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Res..
AQ
08/12VIRACTA THERAPEUTICS : Reports Second Quarter 2021 Financial Results and Provides Clinical..
PU
08/12VIRACTA THERAPEUTICS, INC. : Financial Statements and Exhibits, Regulation FD Disclosure (..
AQ
08/12SUNESIS : Q2 Earnings Snapshot
AQ
08/12VIRACTA : Therapeutics Reports Second Quarter 2021 Financial Results and Provides Clinical..
PR
07/21VIRACTA THERAPEUTICS : Announces FDA Clearance of IND Application for Phase 1b/2 Trial in ..
PU
07/21VIRACTA THERAPEUTICS, INC. : Other Events, Financial Statements and Exhibits (form 8-K)
AQ
07/21VIRACTA THERAPEUTICS : Announces FDA Clearance of IND Application for Phase 1b/2 Trial in ..
PR
07/07VIRACTA THERAPEUTICS : Announces the Appointment of Ayman El-Guindy, Ph.D., as Chief Scien..
AQ
07/06VIRACTA THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
06/29VIRACTA THERAPEUTICS : Announces its Addition to the Russell 2000 Index and other FTSE Rus..
AQ
06/28VIRACTA THERAPEUTICS : Announces its Addition to the Russell 2000® Index and other FTSE Ru..
PR
06/18SUNESIS : Q1 Earnings Snapshot
AQ
06/03VIRACTA THERAPEUTICS : Jefferies Virtual Healthcare Conference Presentation
PU
05/28VIRACTA THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Creation of a Dir..
AQ
05/28VIRACTA THERAPEUTICS : At-The-Market Agreement (Form 8-K)
PU
05/28VIRACTA THERAPEUTICS : to Present at the Jefferies Virtual Healthcare Conference
AQ
05/20VIRACTA THERAPEUTICS : Kol
PU
05/19VIRACTA THERAPEUTICS : to Host Key Opinion Leader Webinar
AQ
05/14VIRACTA THERAPEUTICS : Reports First Quarter 2021 Financial Results and Provides Clinical ..
PU
05/13VIRACTA THERAPEUTICS : Management's Discussion and Analysis of Financial Condition and Res..
AQ
05/12VIRACTA THERAPEUTICS, INC. : Financial Statements and Exhibits, Other Events (form 8-K)
AQ
04/14VIRACTA THERAPEUTICS, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (..
AQ
04/09VIRACTA THERAPEUTICS : to Present at the 20th Annual Needham Virtual Healthcare Conference
AQ
04/01VIRACTA THERAPEUTICS, INC. : Change in Directors or Principal Officers (form 8-K)
AQ
03/23VIRACTA THERAPEUTICS, INC. : Entry into a Material Definitive Agreement, Completion of Acq..
AQ
03/23VIRACTA THERAPEUTICS : Financial Statements and Exhibits (form 8-K/A)
AQ
03/04VIRACTA THERAPEUTICS, INC. : Change in Directors or Principal Officers, Regulation FD Disc..
AQ
03/03VIRACTA : Therapeutics to Participate at H.C. Wainwright Global Life Sciences Conference
PR
Upcoming event on VIRACTA THERAPEUTICS, INC.
12/11/21